EUVIMEDEUVIMED entdecken
EditorialKommentarOpen Access

Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?

Lina Ya'Qoub, Hend Mansoor, Islam Y Elgendy iD

Journal of the American Heart Association · 19.09.2023 · 12 (18)

DOI: 10.1161/jaha.123.031615 ↗

Kurz gefasst

Editorial in der Zeitschrift Journal of the American Heart Association, erschienen am 19.09.2023. Verfasst von Lina Ya'Qoub und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Saint Mary's Regional Medical Center Reno NV USA. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Acute Coronary Syndrome. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ipid-lowering therapy (LLT) is a cornerstone in the management of patients with acute coronary syndrome (ACS). 1 Statins are 3- hydroxy- 3-methy lglutaryl-coenzyme A reductase inhibitors, which reduce low-density lipoprotein cholesterol (LDL-C) levels and subsequent cardiovascular events. 1 Statins not only lower LDL-C levels but also exert beneficial anti-inflammatory effects among patients with ACS (ie, pleiotropic effect). 1,2 Statins are linked with subjective myalgia (ie, muscle pain with normal enzymes)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydroxymethylglutaryl-CoA Reductase InhibitorsAcute Coronary SyndromeHumansEzetimibePropensity ScoreCombined Modality Therapy

Stichwörter der Autor:innen

Editorialsacute coronary syndromeezetimibelipid lowering therapystatin

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsEzetimibe

Autor:innen und Institutionen

  • Department of Cardiology Saint Mary's Regional Medical Center Reno NV USA.
  • Department of Pharmacy, Practice and Science, College of Pharmacy University of Kentucky Lexington KY USA.
  • Division of Cardiovascular Medicine Gill Heart Institute, University of Kentucky Lexington KY USA.

ORCID-Profile: Islam Y Elgendy

Zitieren

APA

Ya'Qoub, L., Mansoor, H., & Elgendy, I. Y. (2023). Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?. Journal of the American Heart Association, 12(18). https://doi.org/10.1161/jaha.123.031615

Vancouver

Ya'Qoub L, Mansoor H, Elgendy IY. Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?. Journal of the American Heart Association. 2023;12(18). doi:10.1161/jaha.123.031615

BibTeX
@article{YaQoub2023,
  author = {Ya'Qoub, Lina and Mansoor, Hend and Elgendy, Islam Y},
  title = {Upfront Combination of Statin and Ezetimibe for Patients With Acute Coronary Syndrome: Time for a New Approach?},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {18},
  doi = {10.1161/jaha.123.031615}
}
Kostenlos starten →